ES2036199T3 - Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal. - Google Patents
Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.Info
- Publication number
- ES2036199T3 ES2036199T3 ES198787112412T ES87112412T ES2036199T3 ES 2036199 T3 ES2036199 T3 ES 2036199T3 ES 198787112412 T ES198787112412 T ES 198787112412T ES 87112412 T ES87112412 T ES 87112412T ES 2036199 T3 ES2036199 T3 ES 2036199T3
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- obtaining
- pharmaceutical preparation
- administrable pharmaceutical
- body membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
LA APLICACION DESCRIBE UNA COMPOSICION ADMINISTRABLE QUE CONSTA DE: A) ENTRE UN 0,2 % Y UN 5% DE UN AGENTE BIOACTIVO, B) ENTRE UN 1% Y UN 20% DE UN COMPONENTE GRASO, Y C) ENTRE UN 80 Y UN 99% DE UN COMPONENTE SECUNDARIO. TAMBIEN SE DESCRIBE EL PROCEDIMIENTO PARA SU PREPARACION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/900,865 US4908389A (en) | 1986-08-27 | 1986-08-27 | Penetration enhancement system |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2036199T3 true ES2036199T3 (es) | 1993-05-16 |
Family
ID=25413211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198787112412T Expired - Lifetime ES2036199T3 (es) | 1986-08-27 | 1987-08-26 | Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4908389A (es) |
EP (1) | EP0261429B1 (es) |
JP (1) | JPS63126832A (es) |
AT (1) | ATE53301T1 (es) |
CA (1) | CA1316825C (es) |
DE (1) | DE3763011D1 (es) |
ES (1) | ES2036199T3 (es) |
GR (1) | GR3000536T3 (es) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4788064A (en) * | 1987-07-31 | 1988-11-29 | Warner-Lambert Company | Transdermal delivery system |
US4994267A (en) * | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
US5164406A (en) * | 1988-06-02 | 1992-11-17 | Bristol-Myers Squibb Co. | Method for enhancing transdermal penetration and compositions useful therein |
US5736553A (en) * | 1988-12-15 | 1998-04-07 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine |
US5238944A (en) * | 1988-12-15 | 1993-08-24 | Riker Laboratories, Inc. | Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine |
US5241925A (en) * | 1988-12-27 | 1993-09-07 | Dermamed | Apparatus and techniques for administering veterinary medicaments |
US5332577A (en) * | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
US5053227A (en) * | 1989-03-22 | 1991-10-01 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
US5059426A (en) * | 1989-03-22 | 1991-10-22 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
ZA906472B (en) * | 1989-08-17 | 1991-05-29 | Schering Corp | Transdermal nitroglycerin patch with penetration enhancers |
US5262165A (en) * | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
DK0497919T3 (da) * | 1989-10-23 | 1997-06-09 | Theratech Inc | Iontoforesenordning, der anvender en hastighedsstyrende membran |
AR246186A1 (es) * | 1989-11-17 | 1994-07-29 | Beta Pharm Co | Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica. |
US5324521A (en) * | 1989-12-18 | 1994-06-28 | Dermamed | Systems for transdermal administration of medicaments |
AU653156B2 (en) * | 1990-06-14 | 1994-09-22 | Dermamed | Transdermal administration to humans and animals |
SE9003665D0 (sv) * | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
TW206152B (es) * | 1991-03-20 | 1993-05-21 | Kuko Seiyaku Kk | |
GB9109965D0 (en) * | 1991-05-07 | 1991-07-03 | Unilever Plc | Cosmetic composition |
US5518734A (en) * | 1991-09-25 | 1996-05-21 | Beta Pharmaceuticals Co. | Transdermal delivery system for estradiol and process for manufacturing said device |
US5705185A (en) * | 1991-09-25 | 1998-01-06 | Beta Pharmaceuticals Co. | Transdermal delivery of estradiol and process for manufacturing said device |
US5229130A (en) * | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
US5453279A (en) * | 1992-04-21 | 1995-09-26 | Tbs Laboratories, Inc. | Enhancing transdermal absorption compositions; transdermal dosage form; and process |
US5900250A (en) * | 1992-05-13 | 1999-05-04 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutnin |
NZ275615A (en) * | 1993-09-29 | 1996-11-26 | Alza Corp | Oxybutynin composition containing monoglyceride and lactate ester as permeability enhancers; device for transdermal administration of oxybutynin |
US5601839A (en) * | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
US6290986B1 (en) * | 1996-10-24 | 2001-09-18 | Pharmaceutical Applications Associates, Llc | Method and composition for transdermal administration of pharmacologic agents |
US20060002959A1 (en) * | 1996-11-14 | 2006-01-05 | Government Of The United States | Skin-sctive adjuvants for transcutaneous immuization |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US20060002949A1 (en) * | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
ES2174490T3 (es) * | 1997-09-25 | 2002-11-01 | Lohmann Therapie Syst Lts | Sales de adicion de acido de alcaloide de morfina y su utilizacion. |
US20040258703A1 (en) * | 1997-11-14 | 2004-12-23 | The Government Of The Us, As Represented By The Secretary Of The Army | Skin-active adjuvants for transcutaneous immunization |
EP1143950B1 (de) * | 1998-09-10 | 2005-03-09 | BioEqual AG | Topisch anwendbare mittel gegen nagelpilzerkrankungen |
EP2368575B1 (en) * | 1999-04-08 | 2014-10-01 | Intercell USA, Inc. | Dry formulation for transcutaneous immunization |
IL137559A (en) * | 2000-07-27 | 2006-12-31 | Amnon Sintov | A system for administering drugs through the skin |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US7527802B2 (en) * | 2001-02-13 | 2009-05-05 | The United States Of America As Represented By The Secretary Of The Army | Vaccine for transcutaneous immunization |
WO2002089853A2 (en) * | 2001-05-03 | 2002-11-14 | Allergan, Inc. | Compositions having enhanced pharmacokinetic characteristics |
GB0218811D0 (en) * | 2002-08-14 | 2002-09-18 | Cenes Ltd | Salts of morphine-6-glucuronide |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
US9498454B2 (en) | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
PT1670433E (pt) | 2003-10-10 | 2012-02-08 | Ferring Bv | Fórmula farmacológica transdérmica para a minimização de resíduos na pele |
US20080139507A1 (en) * | 2004-08-26 | 2008-06-12 | Bioderm Research | Method of Treating Skin Condition Including Acne, Skin Aging, Body Odor & Diaper Rash by Zinc Zeolite Clathrates |
US20070166255A1 (en) * | 2004-11-22 | 2007-07-19 | Gupta Shyam K | Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition |
US8080560B2 (en) * | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
JP5007800B2 (ja) * | 2004-12-27 | 2012-08-22 | ライオン株式会社 | 育毛剤 |
US8067399B2 (en) | 2005-05-27 | 2011-11-29 | Antares Pharma Ipl Ag | Method and apparatus for transdermal or transmucosal application of testosterone |
US8889154B2 (en) | 2005-09-15 | 2014-11-18 | Medicis Pharmaceutical Corporation | Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation |
EP2004297A2 (en) * | 2006-04-04 | 2008-12-24 | The Trustees of Columbia University in the City of New York | Two pore channels as a therapeutic target to protect against myocardial ischemia and as an adjuvant in cardiac surgery |
CA2646667C (en) | 2006-04-21 | 2014-03-11 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
NO343857B1 (no) * | 2006-07-18 | 2019-06-24 | Meda Ab | Immunresponsmodifiserende skumformuleringer |
AU2007279376B2 (en) * | 2006-07-31 | 2012-09-06 | Wirra Ip Pty Ltd | Immune response modifier compositions and methods |
CN101677994B (zh) * | 2007-04-11 | 2015-07-22 | 药品生产公司 | 褪黑激素片剂及制备和使用的方法 |
WO2009075324A1 (ja) * | 2007-12-12 | 2009-06-18 | Teikoku Seiyaku Co., Ltd. | ロキソプロフェン含有水性貼付剤 |
WO2013078422A2 (en) | 2011-11-23 | 2013-05-30 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2015179782A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1165240A (en) * | 1980-07-09 | 1984-04-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
EP0095813A3 (en) * | 1982-06-01 | 1985-05-08 | THE PROCTER & GAMBLE COMPANY | Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine |
US4552872A (en) * | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
JPS6013711A (ja) * | 1983-06-21 | 1985-01-24 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | コルチコステロイドを含有する浸透局所製薬組成物 |
DE3343530A1 (de) * | 1983-12-01 | 1985-06-13 | Max Planck Gesellschaft | Arzneimittel mit verbesserter penetration der gewebsmembran |
CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
-
1986
- 1986-08-27 US US06/900,865 patent/US4908389A/en not_active Expired - Fee Related
-
1987
- 1987-08-21 CA CA000545060A patent/CA1316825C/en not_active Expired - Fee Related
- 1987-08-26 JP JP62210362A patent/JPS63126832A/ja active Pending
- 1987-08-26 ES ES198787112412T patent/ES2036199T3/es not_active Expired - Lifetime
- 1987-08-26 AT AT87112412T patent/ATE53301T1/de not_active IP Right Cessation
- 1987-08-26 EP EP87112412A patent/EP0261429B1/en not_active Expired - Lifetime
- 1987-08-26 DE DE8787112412T patent/DE3763011D1/de not_active Revoked
-
1990
- 1990-06-07 GR GR90400314T patent/GR3000536T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA1316825C (en) | 1993-04-27 |
DE3763011D1 (de) | 1990-07-12 |
EP0261429A1 (en) | 1988-03-30 |
ATE53301T1 (de) | 1990-06-15 |
US4908389A (en) | 1990-03-13 |
EP0261429B1 (en) | 1990-06-06 |
GR3000536T3 (en) | 1991-07-31 |
JPS63126832A (ja) | 1988-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2036199T3 (es) | Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal. | |
NO870241L (no) | Hypoglykemiske tiazolidindioner. | |
ZA895090B (en) | Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds | |
NO157212C (no) | Fremgangsmaate for fremstilling av belegg med lav emisjonsevne. | |
GR3005035T3 (es) | ||
AU7546887A (en) | Variants of lav viruses, their dna- and protein-components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions | |
FR2591485B1 (fr) | Compositions stabilisees contenant l'activateur du plasminogene du tissu humain. | |
NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
ES512894A0 (es) | "un procedimiento para obtener de orina una fraccion que contiene un ingrediente antineoplastico de naturaleza peptidica". | |
SE8602241D0 (sv) | Hudregenererande och hydratiserande kosmetiska kompositioner och forfarande for framstellning av den aktiva ingrediensen | |
ES2037742T3 (es) | Procedimiento de obtencion de una composicion para administracion intravenosa. | |
NO166281C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater. | |
NO883750L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
OA07525A (fr) | Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés. | |
NO165071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre. | |
NO910874D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
JPS52139713A (en) | Sustained release cefalexin preparations | |
NO873514D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser. | |
ZA83856B (en) | Thiazaspirane derivatives,processes for their preparation,and medicaments | |
BG90414A (bg) | 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им | |
SE8503447D0 (sv) | Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen | |
GB2134783A (en) | Medical preparation having antitumoral effect | |
JPS53127432A (en) | Novel physiologically active substance, anthglutin, and its preparation | |
ES2023670B3 (es) | Procedimiento de preparacion de una mezcla que contiene ciclohexanol y ciclohexanona a partir de ciclohexano. | |
JPS53127808A (en) | Preparation of human albumin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 261429 Country of ref document: ES |